| currently | 20 | temporal |
| with the expectation | 6 | other |
| for ovarian cancer | 4 | other |
| drug → be in → phase | 58 |
| drug → be tested in → phase | 22 |
| drug → be studied in → phase | 6 |
| negative | neutral | positive |
| 0.107 | 0.677 | 0.216 |
| Raw frequency | 86 |
| Normalized frequency | 0.447 |
| Modifier score | 0.864 |
| Perplexity | 430.737 |